Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2025-12-26 @ 4:16 AM
NCT ID: NCT01675427
Description: Safety Population: Of the 4766 participants enrolled, 33 did not undergo blood sampling and were thus excluded from the safety analysis. Only serious adverse events caused by a protocol-mandated intervention during the single study visit (Study Visit 1) were assessed; nonserious adverse events were not documented in the course of the study.
Frequency Threshold: 0
Time Frame: Study Visit 1
Study: NCT01675427
Study Brief: A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Participants With CHC Both treatment-naive and treatment-experienced participants with CHC were enrolled in this prospective, interventional Phase 4 study. None None 0 4733 0 0 View
Serious Events(If Any):
Other Events(If Any):